Skip to main content
. 2023 Jan 16;16:7. doi: 10.1186/s12920-023-01437-7

Table 1.

Classification of variants according to ENIGMA [16]

Class Description Probability of being Pathogenic Clinical implication [16]
According to IARC [9] According to ACMG/AMP [19]
1 Benign (B)/ of no clinical significance  < 0.001  < 0.001

Treat as if ‘no mutation detected’ for this disorder

No Predictive testing of at risk relatives is suggested

2 Likely benign (LB)/ of little clinical significance 0.001–0.049 0.001–0.099
3 Variant of unknown significance (VUS) 0.050–0.949 0.100–0.899

Surveillance based on family history and patient-based risk factors

Obtaining additional data in order to reclassify, if possible

Research testing of family members can be recommended

4 Likely pathogenic (LP) 0.950–0.999 0.900–0.999

Full high-risk surveillance

Predictive testing of at-risk relatives is suggested

5 Pathogenic (P)  > 0.999  > 0.999

In our study, we do not distinguish between pathogenic and likely pathogenic outcomes, but refer to them as P/LP